Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 31.32M P/E - EPS this Y - Ern Qtrly Grth -
Income -20.89M Forward P/E -0.63 EPS next Y - 50D Avg Chg -5.00%
Sales 326k PEG - EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 1.64 EPS next 5Y - 52W High Chg -48.00%
Recommedations 2.00 Quick Ratio 6.88 Shares Outstanding 5.47M 52W Low Chg 17.00%
Insider Own 23.52% ROA -30.67% Shares Float 2.98M Beta 1.60
Inst Own 10.28% ROE -206.07% Shares Shorted/Prior 6.85K/11.09K Price 0.76
Gross Margin 98.77% Profit Margin - Avg. Volume 79,006 Target Price -
Oper. Margin -6,285.42% Earnings Date Nov 11 Volume 67,501 Change 3.53%
About Pluri Inc.

Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.

Pluri Inc. News
11/15/24 Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)
11/12/24 Pluri: Fiscal Q1 Earnings Snapshot
11/11/24 BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
10/28/24 Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority
09/11/24 Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
07/18/24 Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
07/08/24 Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
06/18/24 Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
06/06/24 U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
05/20/24 Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
05/12/24 Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)
05/02/24 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
04/08/24 Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
03/28/24 Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
03/27/24 Pluri Inc. Announces 1-for-8 Reverse Share Split
06:00 AM Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
03/19/24 Engage with Pluri's Talent: Exciting Conference Appearances Ahead
03/14/24 Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
03/11/24 Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
03/06/24 Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board
PLUR Chatroom

User Image PLURI_JUGGERNAUT_ Posted - 5 hours ago

$PLUR Climate Change Is Coming for these Food Staples, So Technology is Taking Farming into the Lab https://techbullion.com/climate-change-is-coming-for-these-food-staples-so-technology-is-taking-farming-into-the-lab/

User Image Avi1970 Posted - 8 hours ago

$PLUR plur has A patent portfolio that includes 140 approved patents...We need patience

User Image Avi1970 Posted - 9 hours ago

$PLUR flur holdings : ever after food 41 million dollar , the factory estimated 100 million , the cdmo ...the coffe..the plx-r18 ... Much more then 15 dollar..

User Image Bumbleclod Posted - 13 hours ago

$PLUR OMG now we're back to the bogus ARS pump, with the fake nuclear threat from Russia. They're playbook here is so predictable. They've been trying this one for the last 10 years or more........ Next it'll be the fake meat pump haven't seen that in a while......... Guys you need to come up with something a little more original to really get a pump here, Poor management, you guys really just need to come up with new material lol

User Image Avi1970 Posted - 1 day ago

$PLUR https://www.globenewswire.com/news-release/2024/06/06/2894531/11974/en/U-S-National-Institutes-of-Health-Exercises-Option-to-Fund-1-4-Million-2nd-Year-Budget-for-Pluri-s-PLX-R18-Acute-Radiation-Syndrome-Contract.html Just remember plx-r18

User Image Avi1970 Posted - 1 day ago

$PLUR 8 dollar very soon

User Image Bumbleclod Posted - 1 day ago

$PLUR opened @6-6.05 now give me my 4.40 to close......

User Image Jaimedav Posted - 2 days ago

$PLUR …Ha Ha… another meaningless headline..no pump just Dump..

User Image PLURI_JUGGERNAUT_ Posted - 2 days ago

$PLUR Commodity Markets at Risk for Destabilization as Tech Takes Farming Into the Lab Pluri Is Going To Do Coffee & Chocolate IMO !!! WOW !!! https://www.investing.com/analysis/commodity-markets-at-risk-for-destabilization-as-tech-takes-farming-into-the-lab-200654186

User Image Bumbleclod Posted - 3 days ago

$PLUR More like a gap fill to ZERO........

User Image BigQuench Posted - 1 week ago

$PLUR This is setting up for gap-fill to $7. Easy technical trade... Alerted at $5.

User Image Bumbleclod Posted - 1 week ago

$PLUR Getting setup to trap some newbies............. I'll be opening a short here.....

User Image PLURI_JUGGERNAUT_ Posted - 1 week ago

$PLUR Thursday: November 21st @ 9:00 AM EST Pluri CEO Investor Presentation https://www.webcaster4.com/Webcast/Page/3075/51643

User Image PLURI_JUGGERNAUT_ Posted - 1 week ago

$PLUR November Investor Presentation https://pluri-biotech.com/presentation/

User Image DjStockTrades Posted - 1 week ago

$PLUR interesting setup $AZI $BTCS $CERO $SNSE

User Image BioRich Posted - 1 week ago

$PLUR have held this long and wish I would have averaged down. Still may since this has huge potential. Had just been off my radar for a bit. Cheers!

User Image MadMaverick Posted - 1 week ago

$PLUR $BTCT $CERO $FOXO Recent news for $PLUR 👇 Brainstorm Cell Therapeutics and Pluri Shares Are Trading Higher After the Companies Entered Into a Memorandum of Understanding to Manufacture NurOwn for a Phase 3b Trial in Amyotrophic Lateral Sclerosis.

User Image mdenator Posted - 1 week ago

$CERO $PLUR next

User Image mdenator Posted - 1 week ago

$PLUR 🤙🏻🤙🏻

User Image MadMaverick Posted - 1 week ago

$PLUR low float small cap showing signs of a reversal . Bullish signal on the daily chart 👀 #stockmarket #stocksinnews $BTCT $CERO $FOXO

User Image PLURI_JUGGERNAUT_ Posted - 1 week ago

$PLUR Placenta-Derived Mesenchymal Stromal-Like Cells Promote 3D-Engineered Muscle Tissue Differentiation and Vessel Network Maturation https://onlinelibrary.wiley.com/doi/10.1002/smsc.202470045

User Image Jaimedav Posted - 1 week ago

$PLUR .. another BS headline another pipe dream.. Co is a fraud filled with non tangible contracts that never materialize

User Image PLURI_JUGGERNAUT_ Posted - 1 week ago

$PLUR BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing https://finance.yahoo.com/news/brainstorm-cell-therapeutics-pluri-partner-110000497.html

User Image DonCorleone77 Posted - 1 week ago

$BCLI $PLUR BrainStorm enters MOU with Pluri to support NurOwn trial BrainStorm (BCLI) announced that it has entered into a memorandum of understanding, or MOU, with Pluri (PLUR) through its wholly owned subsidiary to manufacture NurOwn for use in BrainStorm's planned Phase 3b trial in amyotrophic lateral sclerosis, or ALS. This MOU enables BrainStorm to begin transfer of its manufacturing technology and start producing NurOwn at Pluri's manufacturing facility upon finalizing the binding definitive agreement. Under the terms of the proposed agreement, Pluri will provide GMP-compliant manufacturing of NurOwn at its facilities in Israel. This collaboration aims to fulfill essential supply requirements of NurOwn as BrainStorm advances its Phase 3b clinical trial. Additionally, the two companies are exploring options for manufacturing to support potential future commercial distribution, pending approval of NurOwn. The Phase 3b trial has been designed to enroll up to approximately 200 participants with ALS. It will be conducted in two parts: In Part A, participants will receive 3 doses of NurOwn or placebo for 24 weeks. This will be followed by an open label period, during which patients from both arms will receive 3 doses NurOwn for another 24 weeks. The primary efficacy endpoint will be a comparison of change in ALSFRS-R from baseline to week-24 for NurOwn vs. placebo. Successful completion of Part A of the double-blind Phase 3b study will position BrainStorm to submit a Biologics License Application, or BLA, for regulatory approval, potentially accelerating the path to market.

User Image PLURI_JUGGERNAUT_ Posted - 2 weeks ago

$PLUR Healthy Aging/Longevity Company Coming From Pluri Biotech Soon !!! Future Spin-Offs !!! 1. Ever After Foods 2. Coffeesai 3. Human Longevity https://www.youtube.com/watch?v=2TAfu9PDAF0

User Image PLURI_JUGGERNAUT_ Posted - 2 weeks ago

$PLUR Can a Placenta Cure Cancer ? https://www.biu.ac.il/en/article/582414

User Image PLURI_JUGGERNAUT_ Posted - 2 weeks ago

$PLUR Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability https://www.bioprocessintl.com/deal-making/pluri-birad-bring-tumor-fighting-mait-cells-to-commercial-viability

User Image KingNeptune Posted - 2 weeks ago

$PLUR whoa. Nice movement. Solid green. What's stirring up here?

User Image PLURI_JUGGERNAUT_ Posted - 10/30/24

$PLUR 4 Undervalued Hidden Gems With True Growth Potential https://www.investing.com/analysis/4-undervalued-hidden-gems-with-true-growth-potential-200653457

User Image PLURI_JUGGERNAUT_ Posted - 10/29/24

$PLUR New Company Presentation !!! https://pluri-biotech.com/presentation/

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
CLOVER WOLF CAPITAL - LIMITED... 10% Owner 10% Owner Jun 01 Sell 3.7 355,570 1,315,609 3,121,918 06/01/21
CLOVER WOLF CAPITAL - LIMITED... 10% Owner 10% Owner May 27 Sell 3.88 410,376 1,592,259 3,477,488 05/27/21
CLOVER WOLF CAPITAL - LIMITED... 10% Owner 10% Owner Sep 24 Buy 9.02 10,734 96,821 3,740,471 09/24/20